Research Topics


Pharmacokinetic-Pharmacodynamic (PK/PD) Analyses in the Assessment of Abuse-Deterrent Opioid Formulations (ADFs)

Abuse Deterrent Science Meeting

Summary and Discussion Points for Pharmacokinetic (Category2) & Clinical Abuse Potential Studies (Category3):

Interpretation of Human Abuse Potential Studies and Clinically Important Responses to ADFs:

Structuring the Submission of Abuse Deterrence Data and Formulating the ADF Label:

PK/PD analysis in assessment of abuse deterrence: